Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.6 (
CAD
)
4,420
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hereby we report our observations derived from a pilot-study of 39 subjects (30 patients with coronary artery disease [
CAD
] and 9 non-
CAD
controls). In this work, we aimed to evaluate MPO-
ANCA
titer in the human coronary circulation for the first time; and examine its possible association with
CAD
and some cytokines/inflammatory markers. We found higher mean coronary MPO-
ANCA
titer in
CAD
subjects than in non-
CAD
controls; beside significant positive correlations between MPO-
ANCA
titers and both C-reactive protein and interleukin-6 levels. Thus, we might suggest the possible involvement of MPO-
ANCA
in coronary atherogenesis indirectly through modulating some pro-inflammatory cytokines/markers; that a large-scale study of MPO-
ANCA
in
CAD
patients may be warranted in the future.
...
PMID:A pilot-controlled study of myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) in the coronary circulation. 1765 36